カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

放射線量管理の世界市場予測（～2028）：提供別、モダリティ別、収益モデル別、用途別、エンドユーザー別

■ 英語タイトル：Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：HIT3247-24）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：HIT3247-24
■ 発行日：2024年1月11日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：282
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥702,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥944,300見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,157,300見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[放射線量管理の世界市場予測（～2028）：提供別、モダリティ別、収益モデル別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

“世界の放射線量管理市場は、2023年の343百万米ドルから2028年には654百万米ドルに達し、2023年から2028年までの年平均成長率は13.8％と予測”市場の成長を牽引しているのは、慢性疾患の罹患率の上昇と放射線被曝に関する懸念の高まりです。また、画像診断への依存度が高まっていることを反映して、医療施設全体における放射線機器の設置台数が増加していることも、市場の追い風となっています。さらに、放射線量管理に関する意識の高まりも市場の成長に寄与しています。一方、医療機関における放射線量管理のための標準化された手順や線量プロトコルの欠如は、市場の大きな課題となっています。

“予測期間中、放射線量管理ソリューション分野が最も高い成長を遂げる”
放射線量管理市場は、製品・サービス別に放射線量管理ソリューションと放射線量管理サービス（サポート・保守サービス、導入・統合サービス、コンサルティングサービス、教育・トレーニングサービス）に区分されます。放射線量管理ソリューション分野は、さらにスタンドアロンソリューションと統合ソリューションに細分化されます。統合ソリューションは、放射線量を管理する上で包括的かつ合理的なアプローチを提供するため、予測期間中に最も高いCAGRで成長すると予測されています。さらに、医療システムの複雑化、医療施設内のさまざまな技術の統合、多様な画像モダリティや電子カルテとのシームレスな通信、リアルタイムのデータ交換により、医療従事者は放射線量をより効果的に監視・管理することができます。放射線量管理ソリューションが進化を続ける中、統合ソリューションは依然として礎であり、市場の成長と効果に大きく貢献しています。

“予測期間中に放射線量管理市場で最も高い成長を記録するのは、透視検査とインターベンショナルイメージング分野”
放射線量管理市場はモダリティ別に、コンピュータ断層撮影（CT）、透視・インターベンショナルイメージング、X線撮影、マンモグラフィ、核医学に区分されます。予測期間中、放射線量管理市場で最も高い成長が見込まれるのは、透視検査とインターベンショナルイメージング分野です。これらの処置の需要が増加している背景には、心血管疾患の罹患率の上昇と人口の高齢化があります。透視検査やインターベンショナル検査では、電離放射線を長時間浴びることになるため、患者と医療従事者の双方に潜在的なリスクが生じます。そのため、撮影プロトコルを最適化し、放射線量をリアルタイムで監視し、安全ガイドラインを確実に遵守するための高度な放射線量管理ソリューションの導入に注目が集まっています。さらに、画像処理システムの技術的進歩、医療業界における放射線の安全性と規制遵守への関心の高まりが、この分野における効果的な放射線量管理ソリューションの需要に拍車をかけています。

“予測期間中、APACが最も高いCAGRを記録すると予測”
本レポートでは、放射線量管理市場を北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカの5つの主要地域セグメントに区分しています。予測期間中、最も高い成長率を記録すると予測されているのはAPAC市場です。この地域の市場成長は、インターベンショナル・ラジオロジーと核医学への注目が高まっていること、また放射線療法を必要とする癌の症例数が増加していることに起因しています。さらに、患者の安全を確保し、放射線被ばくを低減するための政府の取り組みや規制が増加していることも、アジア太平洋における放射線量管理市場の成長を促進すると予想されます。

供給側一次インタビューの内訳（企業タイプ別、呼称別、地域別

- 企業タイプ別 ティア1（20％）、ティア2（45％）、ティア3（35％）
- 役職別 Cレベル（30％）、ディレクターレベル（20％）、その他（50％）
- 地域別 北米 (35％)、ヨーロッパ (24％)、アジア太平洋 (25％)、中南米・中東・アフリカ (16％)

レポート掲載企業一覧

o Bayer AG (Germany)
o GE Healthcare (US)
o Philips Healthcare (Netherlands)
o Siemens Healthcare (Germany)
o FUJIFILM Holdings Corporation (Japan)
o Canon Inc. (Japan)
o PACSHealth, LLC (US)
o Sectra AB (Sweden)
o Bracco Imaging S.P.A. (Italy)
o Qaelum N.V. (Belgium)
o Agfa Healthcare (Belgium)
o Novarad Corporation (US)
o Medic Vision (US)
o Guerbet (France)
o Medsquare (France)
o INFINITT Healthcare Co. Ltd. (South Korea)
o Volpara Helath Limited. (New Zealand)
o Medic Vision (Israel)
o Imalogix (US)
o Dedalus S.P.A (Italy)
o Nanjing Perlove Medical Equipment CO., LTD. (China)
o Mirion Technologies, Inc. (US)
o Landauer (US)
o Polimaster (Austria)
o Fortive (US)

調査範囲

当レポートでは、放射線量管理市場を製品・サービス、モダリティ、展開形態、収益モデル、アプリケーション・エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因（促進要因、機会、課題など）を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争状況の詳細を提供します。また、微小市場の成長動向、将来性、放射線量管理市場全体への貢献についても調査しています。主要4地域に関して、市場セグメントの収益を予測しています。


レポート購入の理由

本レポートには以下も含まれています。

- 放射線量管理市場の成長に寄与する主な促進要因（慢性疾患の増加による医療用画像モダリティの使用の増加、放射線被ばくに対する懸念の高まり、放射線機器の設置台数の増加、放射線量管理に対する意識の高まり）、課題（世界全体での線量最適化のためのベンチマーク不足）、機会（インターベンショナルラジオロジーおよび核医学への注目の高まり、小児手術の放射線量管理）の分析しました。
- 製品開発/イノベーション 放射線量管理市場における今後の動向、研究開発活動、新しいソフトウェアの発売に関する詳細な洞察を提供します。
- 市場開発： 有利な新興市場、製品・サービス、展開形態、アプリケーション、収益モデル、モダリティ、用途、エンドユーザー、地域に関する包括的な情報を記載しています。
- 市場の多様化： 放射線量管理市場におけるソフトウェアポートフォリオ、成長地域、最近の開発、投資に関する詳細な情報を記載しています。
- 競合評価： 市場における主要企業の市場シェア、成長戦略、製品提供、企業評価象限、能力に関する詳細な評価を提供しています。

1.　序論
2.　調査方法
3.　エグゼクティブサマリー
4.　プレミアムインサイト
5.　市場概要
6.　世界の放射線量管理市場規模：製品・サービス別
7.　世界の放射線量管理市場規模：モダリティ別
8.　世界の放射線量管理市場規模：展開モデル別
9.　世界の放射線量管理市場規模：収益モデル別
10.　世界の放射線量管理市場規模：用途別
11.　世界の放射線量管理市場規模：エンドユーザー別
12.　世界の放射線量管理市場規模：地域別
13.　競争状況
14.　企業情報
15.　付録

*** レポート目次（コンテンツ）***

1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 INCLUSIONS & EXCLUSIONS 40
1.4 MARKET SCOPE 41
1.4.1 MARKETS COVERED 41
1.4.2 REGIONS COVERED 41
1.4.3 YEARS CONSIDERED 42
1.4.4 CURRENCY CONSIDERED 42
1.5 STAKEHOLDERS 42
1.6 SUMMARY OF CHANGES 43
1.6.1 RECESSION IMPACT: RADIATION DOSE MANAGEMENT MARKET 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 1 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 PRIMARY DATA 46
2.1.2.1 Primary sources 46
2.1.2.2 Key data from primary sources 47
2.1.2.3 Key industry insights 48
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 48
2.2 MARKET SIZE ESTIMATION 49
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 49
2.2.1 MARKET ESTIMATION 49
2.2.2 BOTTOM-UP APPROACH 50
FIGURE 4 BOTTOM-UP APPROACH: RADIATION DOSE MANAGEMENT MARKET 50
2.2.3 TOP-DOWN APPROACH 51
FIGURE 5 TOP-DOWN APPROACH: RADIATION DOSE MANAGEMENT MARKET 51
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 52
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 8 DATA TRIANGULATION METHODOLOGY 54
2.4 STUDY ASSUMPTIONS 54
2.5 RESEARCH LIMITATIONS 55
2.5.1 SCOPE-RELATED LIMITATIONS 55
2.5.2 METHODOLOGY-RELATED LIMITATIONS 55
2.6 RISK ASSESSMENT 55
TABLE 1 RISK ASSESSMENT: RADIATION DOSE MANAGEMENT MARKET 55
2.7 IMPACT OF ECONOMIC RECESSION ON RADIATION DOSE MANAGEMENT MARKET 56
3 EXECUTIVE SUMMARY 57
FIGURE 9 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 10 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION) 58
FIGURE 11 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2023 VS. 2028 (USD MILLION) 58
FIGURE 12 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2023 VS. 2028 (USD MILLION) 59
FIGURE 13 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 60
FIGURE 15 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 61
4 PREMIUM INSIGHTS 62
4.1 RADIATION DOSE MANAGEMENT MARKET OVERVIEW 62
FIGURE 16 RISING INCIDENCE OF CHRONIC DISEASES AND INCREASING CONCERNS OVER RADIATION DOSE EXPOSURE TO DRIVE MARKET 62
4.2 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE 63
FIGURE 17 SOLUTIONS COMMANDED LARGEST SHARE IN NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET IN 2022 63
4.3 GEOGRAPHICAL SNAPSHOT: RADIATION DOSE MANAGEMENT MARKET 64
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 64
4.4 REGIONAL MIX: RADIATION DOSE MANAGEMENT MARKET 65
FIGURE 19 NORTH AMERICA TO COMMAND LARGEST SHARE IN RADIATION DOSE MANAGEMENT MARKET DURING STUDY PERIOD 65
4.5 DEVELOPED VS. EMERGING ECONOMIES: RADIATION DOSE MANAGEMENT MARKET 66
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: RADIATION DOSE MANAGEMENT MARKET 67
5.2.1 DRIVERS 68
5.2.1.1 Increasing use of medical imaging modalities 68
FIGURE 22 COUNT OF IMAGING ACTIVITY IN ENGLAND, ON NHS PATIENTS, MARCH 2021–MARCH 2022 68
TABLE 2 COUNTRY-WISE CANCER INCIDENCE, 2012–2035 69
5.2.1.2 Rising concerns for radiation over-exposure 69
5.2.1.3 Growing installation base of radiology equipment 70
TABLE 3 NUMBER OF CT SCANNERS, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS) 70
TABLE 4 NUMBER OF MAMMOGRAPHY MACHINES, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS) 70
5.2.1.4 Increasing number of radiation awareness programs and campaigns 70
5.2.2 RESTRAINTS 71
5.2.2.1 Lack of safety and protection of patient information and data 71
FIGURE 23 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2021 72
5.2.2.2 Shortage of skilled professionals in healthcare industry 72
5.2.3 OPPORTUNITIES 72
5.2.3.1 Growing focus on interventional radiology and nuclear medicine 72
5.2.3.2 Increasing focus on radiation dose management for pediatric procedures 73
5.2.4 CHALLENGES 73
5.2.4.1 Lack of benchmarking for dose optimization 73
5.2.4.2 High installation and maintenance costs 74
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 74
5.4 INDUSTRY TRENDS 74
5.4.1 GROWING AWARENESS AND INCREASING NUMBER OF EDUCATIONAL INITIATIVES ON RADIATION DOSE MANAGEMENT 74
5.4.2 INCREASING ADOPTION OF DOSE MONITORING AND REPORTING 75
5.4.3 RISING USE OF IMAGE OPTIMIZATION TECHNIQUES 75
5.4.4 GROWING IMPORTANCE AND USE OF ARTIFICIAL INTELLIGENCE 75
5.5 TECHNOLOGY ANALYSIS 76
5.5.1 ARTIFICIAL INTELLIGENCE 76
5.5.2 MACHINE LEARNING 76
5.5.3 NEURAL NETWORKS AND DEEP LEARNING 76
5.6 ECOSYSTEM /MARKET MAP 77
FIGURE 24 ECOSYSTEM/MARKET MAP: RADIATION DOSE MANAGEMENT MARKET 77
5.7 VALUE CHAIN ANALYSIS 77
FIGURE 25 VALUE CHAIN ANALYSIS: RADIATION DOSE MANAGEMENT MARKET 78
5.8 TARIFF AND REGULATORY ANALYSIS 78
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 9 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.8.2 REGULATORY ANALYSIS 81
5.8.2.1 North America 81
5.8.2.1.1 US 81
5.8.2.1.2 Canada 82
5.8.2.2 Europe 82
5.8.2.2.1 UK 83
5.8.2.2.2 Spain 83
5.8.2.3 Asia Pacific 83
5.8.2.3.1 Japan 83
5.8.2.3.2 China 83
5.8.2.3.3 South Korea 84
5.8.2.4 Latin America 84
5.9 PRICING ANALYSIS 84
5.9.1 PRICING OVERVIEW 84
5.9.2 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS) 85
FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION 85
TABLE 10 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS) 85
5.9.3 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS 85
TABLE 11 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS 85
5.10 PORTER’S FIVE FORCES ANALYSIS 86
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: RADIATION DOSE MANAGEMENT MARKET 86
5.10.1 THREAT OF NEW ENTRANTS 86
5.10.2 THREAT OF SUBSTITUTES 86
5.10.3 BARGAINING POWER OF BUYERS 86
5.10.4 BARGAINING POWER OF SUPPLIERS 87
5.10.5 INTENSITY OF COMPETITIVE RIVALRY 87
5.11 PATENT ANALYSIS 87
5.11.1 PATENT PUBLICATION TRENDS FOR RADIATION DOSE MANAGEMENT 87
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2023) 88
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RADIATION DOSE MANAGEMENT (JANUARY 2012–DECEMBER 2023) 88
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR RADIATION DOSE MANAGEMENT PATENT DOCUMENTS 89
TABLE 13 LIST OF MAJOR PATENTS IN RADIATION DOSE MANAGEMENT MARKET 89
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT PRODUCTS/SOLUTIONS/SERVICES 90
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES 91
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES 91
5.12.2 BUYING CRITERIA 91
FIGURE 31 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS 91
TABLE 16 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS 92
5.13 END USER ANALYSIS 92
5.13.1 UNMET NEEDS 92
TABLE 17 UNMET NEEDS IN RADIATION DOSE MANAGEMENT MARKET 92
5.13.2 END USER EXPECTATIONS 93
TABLE 18 END USER EXPECTATIONS IN RADIATION DOSE MANAGEMENT MARKET 93
5.14 KEY CONFERENCES & EVENTS, 2023–2024 94
TABLE 19 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024 94
5.15 INVESTMENT AND FUNDING SCENARIO 95
FIGURE 32 INVESTOR DEALS AND FUNDING IN RADIATION DOSE MANAGEMENT SOARED IN 2021 95
FIGURE 33 MOST VALUED RADIATION DOSE MANAGEMENT FIRMS IN 2022 (USD MILLION) 95
5.16 RADIATION DOSE MANAGEMENT REVENUE MODEL 96
5.16.1 SUBSCRIPTION-BASED MODELS 96
5.16.2 TIERED PRICING STRUCTURE 96
5.16.3 IMPLEMENTATION AND INTEGRATION FEES 96
5.16.4 CONSULTING SERVICES 96
5.16.5 CUSTOMIZATION FEES 96
5.16.6 TRAINING AND EDUCATION PROGRAMS 96
5.16.7 DATA ANALYTICS AND REPORTING ADD-ONS 96
5.16.8 TECHNICAL SUPPORT AND MAINTENANCE 96
5.16.9 PERFORMANCE-BASED MODELS 96
5.17 CASE STUDY ANALYSIS 97
5.17.1 FOCUS ON REDUCING RADIATION DOSE 97
TABLE 20 CASE STUDY 1: NEED TO MANAGE AND TRACK RADIATION DOSE IN PATIENTS 97
5.17.2 REDUCING RADIATION DOSE AND STREAMLINING CLINICAL OPERATIONS 97
TABLE 21 CASE STUDY 2: RISING NEED FOR EFFICIENT SYSTEM AND IMPROVED PATIENT CARE 97
5.17.3 OVERCOMING COVID-19-RELATED CHALLENGES 98
TABLE 22 CASE STUDY 3: ENHANCING PATIENT CARE AND INCREASING WORK-LIFE BALANCE FOR RADIOLOGISTS 98
 
6 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE 99
6.1 INTRODUCTION 100
TABLE 23 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 100
6.2 SOLUTIONS 100
TABLE 24 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 25 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.2.1 STANDALONE SOLUTIONS 101
6.2.1.1 Standalone solutions to dominate radiation dose management solutions segment during forecast period 101
TABLE 26 STANDALONE SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.2.2 INTEGRATED SOLUTIONS 102
6.2.2.1 Cost-effectiveness and increased concern over radiation exposure to propel market 102
TABLE 27 INTEGRATED SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.3 SERVICES 104
TABLE 28 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 29 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 105
6.3.1 SUPPORT & MAINTENANCE SERVICES 105
6.3.1.1 Support & maintenance services to command largest market share during study period 105
TABLE 30 SUPPORT & MAINTENANCE SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.3.2 IMPLEMENTATION & INTEGRATION SERVICES 106
6.3.2.1 Complex healthcare ecosystem and need for seamless integration of advanced technologies to drive segment 106
TABLE 31 IMPLEMENTATION & INTEGRATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3.3 CONSULTING SERVICES 107
6.3.3.1 Need to optimize radiation doses at healthcare facilities to support segment growth 107
TABLE 32 CONSULTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
6.3.4 EDUCATION & TRAINING SERVICES 108
6.3.4.1 Need for skill enhancement programs and hands-on knowledge of applications to drive segment 108
TABLE 33 EDUCATION & TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
 
7 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY 110
7.1 INTRODUCTION 111
TABLE 34 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 111
7.2 COMPUTED TOMOGRAPHY 111
7.2.1 INCREASING NUMBER OF COMPUTED TOMOGRAPHY EXAMINATIONS TO SUPPORT MARKET GROWTH 111
TABLE 35 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 112
7.3 FLUOROSCOPY & INTERVENTIONAL IMAGING 112
7.3.1 INCREASING NUMBER OF COMPLEX INTERVENTIONAL IMAGING PROCEDURES TO DRIVE MARKET 112
TABLE 36 RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY & INTERVENTIONAL IMAGING, BY COUNTRY, 2021–2028 (USD MILLION) 113
7.4 RADIOGRAPHY 113
7.4.1 LOW COST OF X-RAY IMAGING AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 113
TABLE 37 RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.5 MAMMOGRAPHY 114
7.5.1 INCREASING INCIDENCE OF BREAST CANCER TO AID MARKET GROWTH 114
TABLE 38 RADIATION DOSE MANAGEMENT MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION) 115
7.6 NUCLEAR MEDICINE 116
7.6.1 RISING PREVALENCE OF CANCER AND CARDIOVASCULAR DISEASES TO BOOST MARKET GROWTH 116
TABLE 39 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 117
8 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT 118
8.1 INTRODUCTION 119
TABLE 40 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 119
8.2 ON-PREMISE DEPLOYMENT 119
8.2.1 LIMITED COST-EFFECTIVENESS AND LOWER FLEXIBILITY TO LIMIT MARKET 119
TABLE 41 RADIATION DOSE MANAGEMENT MARKET FOR ON-PREMISE DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION) 120
8.3 WEB-BASED DEPLOYMENT 120
8.3.1 INCREASED REQUIREMENT FOR WEB-HOSTED SUPPORT APPLICATIONS TO DRIVE MARKET 120
TABLE 42 RADIATION DOSE MANAGEMENT MARKET FOR WEB-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION) 121
8.4 CLOUD-BASED DEPLOYMENT 121
8.4.1 EASIER ACCESSIBILITY, HIGHER SECURITY, AND GREATER PRIVACY TO DRIVE MARKET 121
TABLE 43 RADIATION DOSE MANAGEMENT MARKET FOR CLOUD-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
9 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL 123
9.1 INTRODUCTION 124
TABLE 44 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 124
9.2 CAPITAL/ANNUAL PURCHASE MODEL 124
9.2.1 GROWING EMPHASIS ON DATA-DRIVEN DECISION-MAKING IN HEALTHCARE TO DRIVE MARKET 124
TABLE 45 RADIATION DOSE MANAGEMENT MARKET FOR CAPITAL/ANNUAL PURCHASE MODEL, BY COUNTRY, 2021–2028 (USD MILLION) 125
9.3 PAY-PER-PROCEDURE MODEL 125
9.3.1 GREATER DISCOUNTS AND EASIER PAYMENT OPTIONS TO PROPEL MARKET 125
TABLE 46 RADIATION DOSE MANAGEMENT MARKET FOR PAY-PER-PROCEDURE MODEL, BY COUNTRY, 2021–2028 (USD MILLION) 126
10 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION 127
10.1 INTRODUCTION 128
TABLE 47 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
10.2 ONCOLOGY 128
10.2.1 LIMITED COMPLICATIONS AND LESSER NUMBER OF SIDE EFFECTS TO HEALTHY TISSUES TO DRIVE MARKET 128
TABLE 48 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND) 129
TABLE 49 RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 130
10.3 CARDIOLOGY 130
10.3.1 RISING USE OF IMAGING TECHNIQUES IN CARDIOVASCULAR INTERVENTIONS TO PROPEL MARKET 130
TABLE 50 RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 131
10.4 DENTAL 132
10.4.1 GROWING RELIANCE ON DIAGNOSTIC IMAGING TECHNIQUES IN DENTISTRY TO SUPPORT MARKET GROWTH 132
TABLE 51 RADIATION DOSE MANAGEMENT MARKET FOR DENTAL, BY COUNTRY, 2021–2028 (USD MILLION) 132
10.5 ORTHOPEDIC 133
10.5.1 INCREASING NUMBER OF ORTHOPEDIC PROCEDURES AND RISING GERIATRIC POPULATION TO PROPEL MARKET 133
TABLE 52 RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDIC, BY COUNTRY, 2021–2028 (USD MILLION) 133
10.6 OTHER APPLICATIONS 134
TABLE 53 RADIATION DOSE MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
 
11 RADIATION DOSE MANAGEMENT MARKET, BY END USER 135
11.1 INTRODUCTION 136
TABLE 54 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 136
11.2 HOSPITALS AND HEALTHCARE SYSTEMS 136
11.2.1 RISING ADOPTION OF ADVANCED DIAGNOSTIC IMAGING SYSTEMS TO DRIVE MARKET 136
TABLE 55 RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS AND HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 138
11.3 AMBULATORY SURGERY CENTERS 138
11.3.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH 138
TABLE 56 RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
11.4 DIAGNOSTIC AND IMAGING CENTERS 139
11.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS AND GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 139
TABLE 57 RADIATION DOSE MANAGEMENT MARKET FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
11.5 OTHER END USERS 140
TABLE 58 RADIATION DOSE MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
12 RADIATION DOSE MANAGEMENT MARKET, BY REGION 142
12.1 INTRODUCTION 143
TABLE 59 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 143
12.2 NORTH AMERICA 144
FIGURE 34 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT 144
TABLE 60 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 61 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 145
TABLE 62 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 63 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 64 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 146
TABLE 65 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 147
TABLE 66 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 147
TABLE 67 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 68 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 148
12.2.1 NORTH AMERICA: RECESSION IMPACT 148
12.2.2 US 149
12.2.2.1 US to command largest share of North American radiation dose management market during forecast period 149
TABLE 69 US: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 149
TABLE 70 US: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 71 US: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 72 US: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 151
TABLE 73 US: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 151
TABLE 74 US: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 151
TABLE 75 US: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 76 US: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 152
12.2.3 CANADA 152
12.2.3.1 Increasing number of radiography procedures to drive market 152
TABLE 77 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 153
TABLE 78 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 79 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 80 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 154
TABLE 81 CANADA: RADIATION DOSE MANAGEMENT MARKET SIZE, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 155
TABLE 82 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 155
TABLE 83 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 84 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 156
12.3 EUROPE 156
TABLE 85 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 86 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 87 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 88 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 158
TABLE 89 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 158
TABLE 90 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 159
TABLE 91 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 159
TABLE 92 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 159
TABLE 93 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 160
12.3.1 EUROPE: RECESSION IMPACT 160
12.3.2 FRANCE 160
12.3.2.1 Rising number of CT procedures in children to propel market 160
TABLE 94 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 161
TABLE 95 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 96 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 97 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 162
TABLE 98 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 163
TABLE 99 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 163
TABLE 100 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 163
TABLE 101 RANCE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 164
12.3.3 GERMANY 164
12.3.3.1 Increasing number of radiography procedures and improving healthcare system to support market growth 164
TABLE 102 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 165
TABLE 103 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 104 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 105 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 166
TABLE 106 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 166
TABLE 107 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 166
TABLE 108 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 109 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 167
12.3.4 UK 167
12.3.4.1 Increasing number of diagnostic imaging modalities and interventional procedures to drive market 167
TABLE 110 UK: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 168
TABLE 111 UK: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 112 UK: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 113 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 169
TABLE 114 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 170
TABLE 115 UK: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 170
TABLE 116 UK: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 117 UK: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 171
12.3.5 ITALY 171
12.3.5.1 Increased government focus on implementing eHealth technologies and stringent EU directives to fuel market growth 171
TABLE 118 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 119 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 120 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 121 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 173
TABLE 122 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 173
TABLE 123 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 173
TABLE 124 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 125 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.3.6 SPAIN 174
12.3.6.1 Increasing prevalence of cancer to propel market 174
TABLE 126 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 127 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 128 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 129 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 176
TABLE 130 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 176
TABLE 131 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 176
TABLE 132 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 133 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 177
12.3.7 REST OF EUROPE 177
TABLE 134 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 178
TABLE 135 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 136 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 137 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 179
TABLE 138 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 179
TABLE 139 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 179
TABLE 140 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
TABLE 141 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 180
12.4 ASIA PACIFIC 181
FIGURE 35 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT 182
TABLE 142 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 143 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 183
TABLE 144 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 145 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 146 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 184
TABLE 147 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 185
TABLE 148 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 185
TABLE 149 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 150 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 186
12.4.1 ASIA PACIFIC: RECESSION IMPACT 186
12.4.2 JAPAN 186
12.4.2.1 Increasing prevalence of cancer and growing geriatric population to fuel market growth 186
TABLE 151 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 187
TABLE 152 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 153 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 154 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 188
TABLE 155 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 189
TABLE 156 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 189
TABLE 157 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 189
TABLE 158 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 190
12.4.3 CHINA 190
12.4.3.1 Large patient pool and increased healthcare spending to aid market growth 190
TABLE 159 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 191
TABLE 160 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 161 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 162 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 192
TABLE 163 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 192
TABLE 164 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 192
TABLE 165 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 193
TABLE 166 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 193
12.4.4 INDIA 193
12.4.4.1 Favorable government policies and improved healthcare infrastructure to support market growth 193
TABLE 167 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 194
TABLE 168 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 194
TABLE 169 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 170 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 195
TABLE 171 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 196
TABLE 172 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 196
TABLE 173 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 196
TABLE 174 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 197
12.4.5 REST OF ASIA PACIFIC 197
TABLE 175 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 198
TABLE 176 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 177 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 178 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 199
TABLE 179 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 199
TABLE 180 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 199
TABLE 181 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 200
TABLE 182 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 200

12.5 LATIN AMERICA 201
TABLE 183 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 184 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 201
TABLE 185 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 186 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 187 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 203
TABLE 188 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 203
TABLE 189 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 203
TABLE 190 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 191 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 204
12.5.1 LATIN AMERICA: RECESSION IMPACT 204
12.5.2 BRAZIL 205
12.5.2.1 Growing emphasis on reducing healthcare costs and increasing government focus on rural healthcare to drive market 205
TABLE 192 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 205
TABLE 193 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 194 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 195 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 207
TABLE 196 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 207
TABLE 197 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 207
TABLE 198 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 199 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 208
12.5.3 MEXICO 208
12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market 208
TABLE 200 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 209
TABLE 201 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 202 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 203 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 210
TABLE 204 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 211
TABLE 205 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 211
TABLE 206 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 207 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 212
12.5.4 REST OF LATIN AMERICA 212
TABLE 208 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 213
TABLE 209 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 210 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 211 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 214
TABLE 212 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 214
TABLE 213 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 215
TABLE 214 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 215
TABLE 215 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 216
12.6 MIDDLE EAST & AFRICA 216
TABLE 216 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 217 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 217
TABLE 218 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 219 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 220 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 218
TABLE 221 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 219
TABLE 222 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 219
TABLE 223 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 219
TABLE 224 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 220
12.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 220
12.6.2 GCC COUNTRIES 220
12.6.2.1 Initiatives for improving health infrastructure to propel market 220
TABLE 225 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 221
TABLE 226 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 227 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 228 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 222
TABLE 229 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 223
TABLE 230 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 223
TABLE 231 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 223
TABLE 232 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 224
12.6.3 REST OF MIDDLE EAST & AFRICA 224
TABLE 233 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 225
TABLE 234 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 235 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 236 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION) 226
TABLE 237 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION) 226
TABLE 238 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION) 227
TABLE 239 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 227
TABLE 240 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 228
13 COMPETITIVE LANDSCAPE 229
13.1 INTRODUCTION 229
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 229
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET 229
13.3 REVENUE SHARE ANALYSIS 230
FIGURE 36 REVENUE SHARE ANALYSIS, 2018–2022 230
13.4 MARKET SHARE ANALYSIS 231
FIGURE 37 MARKET SHARE ANALYSIS, 2022 231
TABLE 242 DEGREE OF COMPETITION: RADIATION DOSE MANAGEMENT MARKET 231
FIGURE 38 RANKING OF KEY COMPANIES IN RADIATION DOSE MANAGEMENT MARKET, 2022 232
13.5 BRAND/SOFTWARE COMPARISON 233
FIGURE 39 TOP TRENDING BRANDS/SOFTWARE IN RADIATION DOSE MANAGEMENT MARKET 233
FIGURE 40 BRAND/SOFTWARE COMPARISON: RADIATION DOSE MANAGEMENT MARKET 234
13.5.1 BAYER AG. 234
13.5.2 GE HEALTHCARE 234
13.5.3 PACSHEALTH, LLC 234
13.5.4 VOLPARA HEALTH LIMITED 235
13.5.5 BRACCO 235
13.6 COMPANY VALUATION AND FINANCIAL METRICS 235
13.7 COMPANY EVALUATION MATRIX 236
13.7.1 STARS 236
13.7.2 EMERGING LEADERS 236
13.7.3 PERVASIVE PLAYERS 236
13.7.4 PARTICIPANTS 236
FIGURE 41 COMPANY EVALUATION MATRIX, 2022 237
13.7.5 COMPANY FOOTPRINT 238
TABLE 243 OVERALL FOOTPRINT 238
TABLE 244 PRODUCT & SERVICE FOOTPRINT 239
TABLE 245 MODALITY FOOTPRINT 240
TABLE 246 REGIONAL FOOTPRINT 241
13.8 START-UP/SME EVALUATION MATRIX 242
13.8.1 PROGRESSIVE COMPANIES 242
13.8.2 RESPONSIVE COMPANIES 242
13.8.3 DYNAMIC COMPANIES 242
13.8.4 STARTING BLOCKS 242
FIGURE 42 START-UP/SME EVALUATION MATRIX, 2022 243
13.8.5 COMPETITIVE BENCHMARKING 244
TABLE 247 DETAILED LIST OF KEY START-UPS/SMES 244
TABLE 248 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 244
13.9 COMPETITIVE SCENARIO 245
13.9.1 PRODUCT LAUNCHES 245
TABLE 249 RADIATION DOSE MANAGEMENT MARKET: PRODUCT LAUNCHES, 2020–2023 245
13.9.2 DEALS 245
TABLE 250 RADIATION DOSE MANAGEMENT MARKET: DEALS, 2020–2023 245
14 COMPANY PROFILES 247
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1 KEY PLAYERS 247
14.1.1 BAYER AG 247
TABLE 251 BAYER AG: COMPANY OVERVIEW 247
FIGURE 43 BAYER AG: COMPANY SNAPSHOT (2022) 248
TABLE 252 BAYER AG: PRODUCT LAUNCHES 249
14.1.2 GE HEALTHCARE 250
TABLE 253 GE HEALTHCARE: COMPANY OVERVIEW 250
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 251
14.1.3 KONINKLIJKE PHILIPS N.V. 253
TABLE 254 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 253
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 254
14.1.4 SECTRA AB 256
TABLE 255 SECTRA AB: COMPANY OVERVIEW 256
FIGURE 46 SECTRA AB: COMPANY SNAPSHOT (2022) 257
14.1.5 AGFA-GEVAERT GROUP 259
TABLE 256 AGFA-GEVAERT GROUP: COMPANY OVERVIEW 259
FIGURE 47 AGFA-GEVAERT GROUP.: COMPANY SNAPSHOT (2022) 260
TABLE 257 AGFA-GEVAERT GROUP: OTHER DEVELOPMENTS 261
14.1.6 SIEMENS HEALTHCARE PRIVATE LIMITED 262
TABLE 258 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW 262
FIGURE 48 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2022) 263
TABLE 259 SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCT LAUNCHES 264
14.1.7 CANON MEDICAL SYSTEMS CORPORATION 265
TABLE 260 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 265
FIGURE 49 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022) 266
14.1.8 PACSHEALTH, LLC 267
TABLE 261 PACSHEALTH, LLC: COMPANY OVERVIEW 267
14.1.9 NOVARAD CORPORATION 268
TABLE 262 NOVARAD CORPORATION: COMPANY OVERVIEW 268
14.1.10 QAELUM N.V. 269
TABLE 263 QAELUM N.V.: COMPANY OVERVIEW 269
TABLE 264 QAELUM N.V.: DEALS 270
14.1.11 BRACCO 271
TABLE 265 BRACCO: COMPANY OVERVIEW 271
14.1.12 GUERBET 272
TABLE 266 GUERBET: COMPANY OVERVIEW 272
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2022) 272
14.1.13 FUJIFILM HOLDINGS CORPORATION 274
TABLE 267 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 274
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 274
TABLE 268 FUJIFILM HOLDINGS CORPORATION: DEALS 275
14.1.14 INFINITT HEALTHCARE CO., LTD. 276
TABLE 269 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW 276
14.1.15 MEDSQUARE 277
TABLE 270 MEDSQUARE: COMPANY OVERVIEW 277
14.1.16 MEDIC VISION 278
TABLE 271 MEDIC VISION: COMPANY OVERVIEW 278
14.1.17 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD. 279
TABLE 272 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 279
14.1.18 VOLPARA HEALTH LIMITED. 280
TABLE 273 VOLPARA HEALTH LIMITED: COMPANY OVERVIEW 280
FIGURE 52 VOLPARA HEALTH LIMITED: COMPANY SNAPSHOT (2022) 280
TABLE 274 VOLPARA HEALTH LIMITED: DEALS 281
14.1.19 MIRION TECHNOLOGIES, INC. 282
TABLE 275 MIRION TECHNOLOGIES, INC.: COMPANY OVERVIEW 282
14.2 OTHER PLAYERS 283
14.2.1 IMALOGIX 283
14.2.2 LANDAUER 283
14.2.3 RAYSEARCH LABORATORIES 283
14.2.4 I-SOLUTIONS HEALTH GMBH 284
14.2.5 MEDIGRATION 284
14.2.6 TECNOLOGIE AVANZATE 285
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
5 APPENDIX 286
15.1 DISCUSSION GUIDE 286
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 290
15.3 CUSTOMIZATION OPTIONS 292
15.4 RELATED REPORTS 292
15.5 AUTHOR DETAILS 293

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脳モニタリングの世界市場予測（～2028）：機器別、付属品別、モダリティ別、疾患別、エンドユーザー別
  • デジタルセラピューティクス（DTx）の世界市場予測（～2028）：提供別、収益モデル別、用途別
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(HIT3247-24 )"放射線量管理の世界市場予測（～2028）：提供別、モダリティ別、収益モデル別、用途別、エンドユーザー別" (英文：Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。